Tilray, Canopy, and Aurora Have 2022 Forecasts Cut

The three largest cannabis producers in Canada just had their 2022 sales forecasts cut by hundreds of millions of dollars.

Tilray (TLRY), Canopy (CGC), and Aurora (ACB) have come under pressure from falling stock prices, poor execution by executive teams, and an increasingly competitive landscape across the adult-use industry.

Continue reading “Tilray, Canopy, and Aurora Have 2022 Forecasts Cut”

Is This Heavily Shorted Cannabis Stock the Next GameStop?

If you are impressed with GameStop’s (GME) meteoric 2,300% gain in a little over two weeks then you need to know about a similar trade that is currently setting up in the cannabis sector.

I am going to reveal two of the most shorted cannabis stocks and explain why a GameStop-style, short squeeze could send shares soaring.

The cannabis sector has long been a favorite target of short sellers. In 2019, and the first half of 2020, this was a very profitable strategy. Continue reading “Is This Heavily Shorted Cannabis Stock the Next GameStop?”

Mexico Ready to Unleash a $2 Billion Market

The United States is dominating the cannabis headlines because four states are set to vote on legalization on November 3 with the U.S. presidential election.

Cannabis investors could have easily missed a huge investment opportunity that is rapidly developing just south of the U.S. border.

Mexico is on the fast track to legalize recreational cannabis – most likely by the end of the year. Continue reading “Mexico Ready to Unleash a $2 Billion Market”

2 Reasons to Avoid Aurora Cannabis

Back in 2019, Aurora Cannabis was the rock star of the cannabis industry. At its peak, Aurora nabbed a market cap of $10 billion.

The company had delivered enormous gains to early investors. It also and ranked as the #1 held stock on the popular stock trading app, Robinhood.

The enthusiasm was driven by Aurora’s impressive portfolio of cannabis businesses and assets.

That portfolio included 15 global cannabis cultivation centers capable of producing more than 700,000 kilograms of cannabis per year. Aurora had also secured exclusive cannabis permits in potentially lucrative international markets including Germany and Australia. Aurora invested hundreds of millions to build an unparalleled global cannabis production and distribution network.

However, customers never showed up. Continue reading “2 Reasons to Avoid Aurora Cannabis”

Avoid This Former Highflier – It May Not Be a Bargain

Investors who love a great deal should be looking at the cannabis sector. Many early industry leaders are trading at a big discount relative to their 52-week highs.

However, not all ‘bargains’ are made the same.

Today I am going to reveal one of the most popular cannabis stocks, down 93% in the last 12 months. That might look like a great bargain on the surface, however, I see more losses ahead. Continue reading “Avoid This Former Highflier – It May Not Be a Bargain”

Aurora Cannabis Looks To Make $3 Billion Merger With CanniMed Therapeutics

Look out, Canopy Growth Corporation. Your reign as the pure-play marijuana stock with the highest market cap might not last for long.

On Tuesday, Aurora Cannabis announced that it had submitted a proposal to acquire all shares of another Canadian marijuana grower, CanniMed Therapeutics. Aurora is offering to buy CanniMed, which trades on the Toronto Stock Exchange, for $24 per share. Continue reading “Aurora Cannabis Looks To Make $3 Billion Merger With CanniMed Therapeutics”